These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25230994)

  • 21. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.
    Jamieson DJ; Clark J; Kourtis AP; Taylor AW; Lampe MA; Fowler MG; Mofenson LM
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S26-32. PubMed ID: 17825647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raltegravir in pregnancy: a case series presentation.
    Taylor N; Touzeau V; Geit M; Gisinger M; Egle A; Greil R; Rieger A; Zangerle R
    Int J STD AIDS; 2011 Jun; 22(6):358-60. PubMed ID: 21680678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP
    J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
    [No Abstract]   [Full Text] [Related]  

  • 25. Is Option B+ the best choice?
    Coutsoudis A; Goga A; Desmond C; Barron P; Black V; Coovadia H
    Lancet; 2013 Jan; 381(9863):269-71. PubMed ID: 23351797
    [No Abstract]   [Full Text] [Related]  

  • 26. National guidelines for the active management of HIV in pregnancy.
    Clarke S; Butler K; Bergin C; Lyons F; Sheehan G; Horgan M; Mulcahy F;
    Ir Med J; 2001 May; 94(5):137-40. PubMed ID: 11474853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feeding of infants of HIV-positive mothers.
    Saloojee H; Cooper PA
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):336-43. PubMed ID: 20125000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations on the potential teratogenic effects of antiretroviral therapy.
    Meli M; Vicidomini S; Bartoloni A
    Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy.
    Islam S; Oon V; Thomas P
    J Obstet Gynaecol; 2010 Jan; 30(1):38-40. PubMed ID: 20121502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 32. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
    Gopalappa C; Stover J; Shaffer N; Mahy M
    AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anaesthesia and intensive care characteristics in HIV-infected pregnant patients receiving the antiretroviral therapy].
    Krugova LV; Vartanov VIa; Vartanova IV; Shakhovskaia IN; Khutorskaia NN; Lapteva IV
    Anesteziol Reanimatol; 2010; (6):32-6. PubMed ID: 21400795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of pregnancy to the use of highly active antiretroviral therapy.
    Minkoff H; Ahdieh L; Watts H; Greenblatt RM; Schmidt J; Schneider M; Stek A
    Am J Obstet Gynecol; 2001 May; 184(6):1221-7. PubMed ID: 11349192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we not pay attention to what women tell us when they vote with their feet?
    Bewley S; Welbourn A
    AIDS; 2014 Aug; 28(13):1995. PubMed ID: 25259709
    [No Abstract]   [Full Text] [Related]  

  • 37. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda.
    Ivan E; Crowther NJ; Mutimura E; Rucogoza A; Janssen S; Njunwa KK; Grobusch MP
    Clin Infect Dis; 2015 Jan; 60(1):135-42. PubMed ID: 25210019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?
    Bulterys M; Wilfert CM
    AIDS; 2009 Nov; 23(18):2473-7. PubMed ID: 19838097
    [No Abstract]   [Full Text] [Related]  

  • 40. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    Herzmann C; Karcher H
    N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.